According to InflaRx
's latest financial reports the company has a price-to-book ratio of 0.6282.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.7699 | -46.84% |
2022-12-31 | 1.45 | -17.9% |
2021-12-31 | 1.76 | 18.98% |
2020-12-31 | 1.48 | 72.14% |
2019-12-31 | 0.8613 | -84.2% |
2018-12-31 | 5.45 | 59.39% |
2017-12-31 | 3.42 | |
2016-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.43 | 286.47% | ๐บ๐ธ USA |